Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1998 Dec;57(12):701–702. doi: 10.1136/ard.57.12.701

Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity

V AGNELLO 1
PMCID: PMC1752515  PMID: 10070267

Full Text

The Full Text of this article is available as a PDF (70.7 KB).

Figure 1  .

Figure 1  

Results of the Italian6 and French7 studies are compared. The prevalences of cirrhosis in essential mixed cryoglobulinaemia (EMC) and in cryoglobulinaemia secondary to chronic liver disease (2° CLD) are shown. The prevalences of the type of cryoglobulinaemia (II or III) and rheumatoid factor (RF) and antibodies to hepatitis C virus antigens (HCV Ab) in the serum are shown for each group. Reprinted from Agnello V,8 with permission of the publisher.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum. 1997 Nov;40(11):2007–2015. doi: 10.1002/art.1780401113. [DOI] [PubMed] [Google Scholar]
  2. Agnello V., Chung R. T., Kaplan L. M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992 Nov 19;327(21):1490–1495. doi: 10.1056/NEJM199211193272104. [DOI] [PubMed] [Google Scholar]
  3. Agnello V. Immune complex assays: the first ten years. Ann Intern Med. 1981 Feb;94(2):266–267. doi: 10.7326/0003-4819-94-2-266. [DOI] [PubMed] [Google Scholar]
  4. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol. 1997;19(1):111–129. doi: 10.1007/BF00945029. [DOI] [PubMed] [Google Scholar]
  5. Brouet J. C., Clauvel J. P., Danon F., Klein M., Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974 Nov;57(5):775–788. doi: 10.1016/0002-9343(74)90852-3. [DOI] [PubMed] [Google Scholar]
  6. Kunkel H. G. Immune complexes and disease. General introduction. J Exp Med. 1971 Sep 1;134(3 Pt 2):1s–3s. [PubMed] [Google Scholar]
  7. Lee Y. H., Ji J. D., Yeon J. E., Byun K. S., Lee C. H., Song G. G. Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann Rheum Dis. 1998 Dec;57(12):728–731. doi: 10.1136/ard.57.12.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lunel F., Musset L., Cacoub P., Frangeul L., Cresta P., Perrin M., Grippon P., Hoang C., Valla D., Piette J. C. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 1994 May;106(5):1291–1300. doi: 10.1016/0016-5085(94)90022-1. [DOI] [PubMed] [Google Scholar]
  9. Meltzer M., Franklin E. C., Elias K., McCluskey R. T., Cooper N. Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med. 1966 Jun;40(6):837–856. doi: 10.1016/0002-9343(66)90200-2. [DOI] [PubMed] [Google Scholar]
  10. Monti G., Galli M., Invernizzi F., Pioltelli P., Saccardo F., Monteverde A., Pietrogrande M., Renoldi P., Bombardieri S., Bordin G. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM. 1995 Feb;88(2):115–126. [PubMed] [Google Scholar]
  11. Musset L., Diemert M. C., Taibi F., Thi Huong Du L., Cacoub P., Leger J. M., Boissy G., Gaillard O., Galli J. Characterization of cryoglobulins by immunoblotting. Clin Chem. 1992 Jun;38(6):798–802. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES